BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
BIO-RAD LABORATORIES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$352.82−0.88 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $9.46B
- P/E (TTM)
- 42.8
- Dividend yield
- –
BIO-RAD LABORATORIES, INC. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 51.9%
- Operating margin
- 2.1%
- Net margin
- 8.6%
- Return on equity, FY2025
- 10.8%
Financial strength
- Current ratio
- 3.14
- Debt to equity
- 0.11
- Debt to assets
- 7.8%
- Cash to current liabilities
- 53.8%
Valuation
- P/E ratio
- 42.8
- Price to sales
- 3.65
- Price to book
- 1.32
- Dividend yield
- –